August 07, 2013
A California federal judge on Tuesday ordered the U.S. Food and Drug Administration to cough up documents related to the supplemental approval of Gilead Sciences Inc.'s drug Truvada as a HIV preventative treatment, ruling the agency had not justified its refusal to release the information.